The reinvention wont surprise anyone who has paid close attention to the companys moves since it launched in 2006 such as when it hired RD veteran Richard Scheller as chief scientific officer in 2015 or when it got an OK in 2017 to market the first FDAauthorized directtoconsumer tests to determine genetic predisposition to certain medical diseases or conditions or just last month when the company extended a drug discovery collaboration with GSK 